International Journal of Endocrinology and Metabolism

Published by: Kowsar

Reproductive Assessment: Findings from 20 Years of the Tehran Lipid and Glucose Study

Fahimeh Ramezani Tehrani 1 , * , Samira Behboudi-Gandevani 1 , Marzieh Rostami Dovom 1 , Maryam Farahmand 1 , Sonia Minooee 1 , Mahsa Noroozzadeh 1 , Mina Amiri 1 , Sima Nazarpour 1 and Fereidoun Azizi 2
Authors Information
1 Reproductive Endocrinology Research Center, Research Institute for Endocrine Sciences, Shahid Beheshti University of Medical Sciences, Tehran, Iran
2 Endocrine Research Center, Research Institute for Endocrine Sciences, Shahid Beheshti University of Medical Science, Tehran, Iran
Article information
  • International Journal of Endocrinology and Metabolism: October 2018, 16 (4 (Suppl)); e84786
  • Published Online: October 20, 2018
  • Article Type: Review Article
  • Received: September 1, 2018
  • Revised: October 2, 2018
  • Accepted: October 7, 2018
  • DOI: 10.5812/ijem.84786

To Cite: Ramezani Tehrani F, Behboudi-Gandevani S, Rostami Dovom M, Farahmand M, Minooee S, et al. Reproductive Assessment: Findings from 20 Years of the Tehran Lipid and Glucose Study, Int J Endocrinol Metab. 2018 ; 16(4 (Suppl)):e84786. doi: 10.5812/ijem.84786.

Abstract
Copyright © 2018, International Journal of Endocrinology and Metabolism. This is an open-access article distributed under the terms of the Creative Commons Attribution-NonCommercial 4.0 International License (http://creativecommons.org/licenses/by-nc/4.0/) which permits copy and redistribute the material just in noncommercial usages, provided the original work is properly cited.
1. Context
2. Evidence Acquisition
3. Results
4. Conclusions
Acknowledgements
Footnote
References
  • 1. Goodman NF, Cobin RH, Futterweit W, Glueck JS, Legro RS, Carmina E, et al. American association of clinical endocrinologists, American college of endocrinology, and androgen excess and pcos society disease state clinical review: Guide to the best practices in the evaluation and treatment of polycystic ovary syndrome--part 1. Endocr Pract. 2015;21(11):1291-300. doi: 10.4158/EP15748.DSC. [PubMed: 26509855].
  • 2. Farahmand M, Ramezani Tehrani F, Azizi F. Whether age of menarche is influenced by body mass index and lipoproteins profile? A retrospective study. Iran J Reprod Med. 2012;10(4):337-42. [PubMed: 25246895]. [PubMed Central: PMC4165951].
  • 3. Ramezani Tehrani F, Mirmiran P, Gholami R, Moslehi N, Azizi F. Factors influencing menarcheal age: Results from the cohort of tehran lipid and glucose study. Int J Endocrinol Metab. 2014;12(3). e16130. doi: 10.5812/ijem.16130. [PubMed: 25237321]. [PubMed Central: PMC4166004].
  • 4. Tehrani FR, Mirmiran P, Zahedi-Asl S, Nakhoda K, Azizi F. Menarcheal age of mothers and daughters: Tehran lipid and glucose study. East Mediterr Health J. 2010;16(4):391-5. doi: 10.26719/2010.16.4.391. [PubMed: 20795422].
  • 5. Juul A, Teilmann G, Scheike T, Hertel NT, Holm K, Laursen EM, et al. Pubertal development in Danish children: Comparison of recent European and US data. Int J Androl. 2006;29(1):247-55. discussion 286-90. doi: 10.1111/j.1365-2605.2005.00556.x. [PubMed: 16466546].
  • 6. Mul D, Fredriks AM, van Buuren S, Oostdijk W, Verloove-Vanhorick SP, Wit JM. Pubertal development in the Netherlands 1965-1997. Pediatr Res. 2001;50(4):479-86. doi: 10.1203/00006450-200110000-00010. [PubMed: 11568291].
  • 7. Hwang JY, Shin C, Frongillo EA, Shin KR, Jo I. Secular trend in age at menarche for South Korean women born between 1920 and 1986: The Ansan study. Ann Hum Biol. 2003;30(4):434-42. doi: 10.1080/0301446031000111393. [PubMed: 12881142].
  • 8. Mahachoklertwattana P, Suthutvoravut U, Charoenkiatkul S, Chongviriyaphan N, Rojroongwasinkul N, Thakkinstian A, et al. Earlier onset of pubertal maturation in Thai girls. J Med Assoc Thai. 2002;85 Suppl 4:S1127-34. doi: 10.1080/03014460400018077. [PubMed: 12549786].
  • 9. Malina RM, Pena Reyes ME, Tan SK, Little BB. Secular change in age at menarche in rural Oaxaca, southern Mexico: 1968--2000. Ann Hum Biol. 2004;31(6):634-46. [PubMed: 15799231].
  • 10. Ramezani Tehrani F, Moslehi N, Asghari G, Gholami R, Mirmiran P, Azizi F. Intake of dairy products, calcium, magnesium, and phosphorus in childhood and age at menarche in the Tehran lipid and glucose study. PLoS One. 2013;8(2). e57696. doi: 10.1371/journal.pone.0057696. [PubMed: 23451261]. [PubMed Central: PMC3581542].
  • 11. Velie EM, Nechuta S, Osuch JR. Lifetime reproductive and anthropometric risk factors for breast cancer in postmenopausal women. Breast Dis. 2005;24:17-35. doi: 10.3233/BD-2006-24103. [PubMed: 16917137].
  • 12. He C, Zhang C, Hunter DJ, Hankinson SE, Buck Louis GM, Hediger ML, et al. Age at menarche and risk of type 2 diabetes: Results from 2 large prospective cohort studies. Am J Epidemiol. 2010;171(3):334-44. doi: 10.1093/aje/kwp372. [PubMed: 20026580]. [PubMed Central: PMC2842205].
  • 13. Lakshman R, Forouhi NG, Sharp SJ, Luben R, Bingham SA, Khaw KT, et al. Early age at menarche associated with cardiovascular disease and mortality. J Clin Endocrinol Metab. 2009;94(12):4953-60. doi: 10.1210/jc.2009-1789. [PubMed: 19880785].
  • 14. Farahmand M, Tehrani FR, Dovom MR, Azizi F. Menarcheal age and risk of type 2 diabetes: A community-based cohort study. J Clin Res Pediatr Endocrinol. 2017;9(2):156-62. doi: 10.4274/jcrpe.3370. [PubMed: 27840328]. [PubMed Central: PMC5463289].
  • 15. Farahmand M, Tehrani FR, Pourrajabi L, Najafi M, Azizi F. Factors associated with menopausal age in Iranian women: Tehran lipid and glucose study. J Obstet Gynaecol Res. 2013;39(4):836-41. doi: 10.1111/j.1447-0756.2012.02050.x. [PubMed: 23279558].
  • 16. Mohammad K, Sadat Hashemi SM, Farahani FK. Age at natural menopause in Iran. Maturitas. 2004;49(4):321-6. doi: 10.1016/j.maturitas.2004.02.006. [PubMed: 15531128].
  • 17. Rodstrom K, Bengtsson C, Milsom I, Lissner L, Sundh V, Bjourkelund C. Evidence for a secular trend in menopausal age: A population study of women in Gothenburg. Menopause. 2003;10(6):538-43. doi: 10.1097/01.GME.0000094395.59028.0F. [PubMed: 14627863].
  • 18. Mollaei E, Hoseinpour F, Fasihi S, Ziaei T. [Age of menarche and its relationship with some factors in the schoolgirls of Gorgan in 2006]. Sci J Nurs Midwifery Facult Bouye Gorgan. 2010;7(1):48-54. Persian.
  • 19. Pakarinen M, Raitanen J, Kaaja R, Luoto R. Secular trend in the menopausal age in Finland 1997-2007 and correlation with socioeconomic, reproductive and lifestyle factors. Maturitas. 2010;66(4):417-22. doi: 10.1016/j.maturitas.2010.04.005. [PubMed: 20537824].
  • 20. McKinlay SM. The normal menopause transition: An overview. Maturitas. 1996;23(2):137-45. doi: 10.1016/0378-5122(95)00985-X. [PubMed: 8735352].
  • 21. Tehrani FR, Solaymani-Dodaran M, Azizi F. A single test of antimullerian hormone in late reproductive-aged women is a good predictor of menopause. Menopause. 2009;16(4):797-802. doi: 10.1097/gme.0b013e318193e95d. [PubMed: 19225427].
  • 22. Tehrani FR, Solaymani-Dodaran M, Tohidi M, Gohari MR, Azizi F. Modeling age at menopause using serum concentration of anti-mullerian hormone. J Clin Endocrinol Metab. 2013;98(2):729-35. doi: 10.1210/jc.2012-3176. [PubMed: 23316087].
  • 23. van Rooij IA, Broekmans FJ, Scheffer GJ, Looman CW, Habbema JD, de Jong FH, et al. Serum antimullerian hormone levels best reflect the reproductive decline with age in normal women with proven fertility: A longitudinal study. Fertil Steril. 2005;83(4):979-87. doi: 10.1016/j.fertnstert.2004.11.029. [PubMed: 15820810].
  • 24. Gunderson EP, Chiang V, Pletcher MJ, Jacobs DR, Quesenberry CP, Sidney S, et al. History of gestational diabetes mellitus and future risk of atherosclerosis in mid-life: The coronary artery risk development in young adults study. J Am Heart Assoc. 2014;3(2). e000490. doi: 10.1161/JAHA.113.000490. [PubMed: 24622610]. [PubMed Central: PMC4187501].
  • 25. Ainy E, Mirmiran P, Zahedi Asl S, Azizi F. Prevalence of metabolic syndrome during menopausal transition Tehranian women: Tehran lipid and glucose study (TLGS). Maturitas. 2007;58(2):150-5. doi: 10.1016/j.maturitas.2007.07.002. [PubMed: 17768019].
  • 26. Ramezani Tehrani F, Behboudi-Gandevani S, Ghanbarian A, Azizi F. Effect of menopause on cardiovascular disease and its risk factors: A 9-year follow-up study. Climacteric. 2014;17(2):164-72. doi: 10.3109/13697137.2013.828197. [PubMed: 23895384].
  • 27. Azizi F, Ainy E. Coronary heart disease risk factors and menopause: A study in 1980 Tehranian women, the Tehran lipid and glucose study. Climacteric. 2003;6(4):330-6. doi: 10.1080/cmt.6.4.330.336. [PubMed: 15006254].
  • 28. Farahmand M, Ramezani Tehrani F, Bahri Khomami M, Noroozzadeh M, Azizi F. Surgical menopause versus natural menopause and cardio-metabolic disturbances: A 12-year population-based cohort study. J Endocrinol Invest. 2015;38(7):761-7. doi: 10.1007/s40618-015-0253-3. [PubMed: 25722224].
  • 29. Tehrani FR, Behboudi-Gandevani S, Ghasemi A, Azizi F. Menopause status as the main factor explaining the gender differences of serum nitric oxide concentrations in middle-aged population. Arch Gynecol Obstet. 2015;291(1):159-63. doi: 10.1007/s00404-014-3338-x. [PubMed: 25047269].
  • 30. Ramezani Tehrani F, Behboudi-Gandevani S, Ghasemi A, Azizi F. Association between serum concentrations of nitric oxide and transition to menopause. Acta Obstet Gynecol Scand. 2015;94(7):708-14. doi: 10.1111/aogs.12655. [PubMed: 25867606].
  • 31. Behboudi-Gandevani S, Ziaei S, Khalajabadi-Farahani F, Jasper M. Iranian primigravid women's awareness of the risks associated with delayed childbearing. Eur J Contracept Reprod Health Care. 2013;18(6):460-7. doi: 10.3109/13625187.2013.832195. [PubMed: 24011122].
  • 32. Motlaq ME, Eslami M, Yazdanpanah M, Nakhaee N. Contraceptive use and unmet need for family planning in Iran. Int J Gynaecol Obstet. 2013;121(2):157-61. doi: 10.1016/j.ijgo.2012.11.024. [PubMed: 23473347].
  • 33. Sadat-Hashemi SM, Ghorbani R, Majdabadi HA, Farahani FK. Factors associated with contraceptive use in Tehran, Iran. Eur J Contracept Reprod Health Care. 2007;12(2):148-53. doi: 10.1080/13625180601143462. [PubMed: 17559013].
  • 34. Azizi F, Ainy E, Mirmiran P, Habibian S. Contraceptive methods and risk factors of cardiovascular diseases in Tehranian women: Tehran lipid and glucose study. Eur J Contracept Reprod Health Care. 2002;7(1):1-6. doi: 10.1080/713604284. [PubMed: 12041858].
  • 35. Behboudi-Gandevani S, Ramezani Tehrani F, Cheraghi L, Noroozzadeh M, Farahmand M, Azizi F. Trends of contraception use among married reproductive age women: Tehran lipid and glucose cohort study 2002-2011. Sex Reprod Healthc. 2017;12:116-22. doi: 10.1016/j.srhc.2017.04.003. [PubMed: 28477923].
  • 36. Farahmand M, Ramezani Tehrani F, Rostami Dovom M, Hashemi S, Azizi F. The impact of oral contraceptives on cardiometabolic parameters. J Endocrinol Invest. 2016;39(3):277-83. doi: 10.1007/s40618-015-0346-z. [PubMed: 26223383].
  • 37. Rostami Dovom M, Ramezani Tehrani F, Abedini M, Amirshekari G, Hashemi S, Noroozzadeh M. A population-based study on infertility and its influencing factors in four selected provinces in Iran (2008-2010). Iran J Reprod Med. 2014;12(8):561-6. [PubMed: 25408706]. [PubMed Central: PMC4233315].
  • 38. Bushnik T, Cook JL, Yuzpe AA, Tough S, Collins J. Estimating the prevalence of infertility in Canada. Hum Reprod. 2012;27(3):738-46. doi: 10.1093/humrep/der465. [PubMed: 22258658]. [PubMed Central: PMC3279129].
  • 39. Alberti KG, Zimmet PZ. Definition, diagnosis and classification of diabetes mellitus and its complications. Part 1: Diagnosis and classification of diabetes mellitus provisional report of a WHO consultation. Diabet Med. 1998;15(7):539-53. doi: 10.1002/(SICI)1096-9136(199807)15:7<539::AID-DIA668>3.0.CO;2-S. [PubMed: 9686693].
  • 40. Gifford R. Report of the national high blood pressure education program working group on high blood pressure in pregnancy. Am J Obstet Gynecol. 2000;183(1):S1-S22. doi: 10.1067/mob.2000.107928. [PubMed: 10920346].
  • 41. Sibai BM, el-Nazer A, Gonzalez-Ruiz A. Severe preeclampsia-eclampsia in young primigravid women: Subsequent pregnancy outcome and remote prognosis. Am J Obstet Gynecol. 1986;155(5):1011-6. doi: 10.1016/0002-9378(86)90336-4. [PubMed: 3777042].
  • 42. Hashemi S, Ramezani Tehrani F, Mehrabi Y, Azizi F. Hypertensive pregnancy disorders as a risk factor for future cardiovascular and metabolic disorders (Tehran lipid and glucose study). J Obstet Gynaecol Res. 2013;39(5):891-7. doi: 10.1111/j.1447-0756.2012.02069.x. [PubMed: 23438323].
  • 43. Azziz R, Carmina E, Sawaya ME. Idiopathic hirsutism. Endocr Rev. 2000;21(4):347-62. doi: 10.1210/edrv.21.4.0401. [PubMed: 10950156].
  • 44. Tehrani FR, Rashidi H, Azizi F. The prevalence of idiopathic hirsutism and polycystic ovary syndrome in the Tehran lipid and glucose study. Reprod Biol Endocrinol. 2011;9:144. doi: 10.1186/1477-7827-9-144. [PubMed: 22044512]. [PubMed Central: PMC3214199].
  • 45. Ramezani Tehrani F, Minooee S, Azizi F. Validation of a simplified method to assess hirsutism in the Iranian population. Eur J Obstet Gynecol Reprod Biol. 2014;174:91-5. doi: 10.1016/j.ejogrb.2013.12.008. [PubMed: 24393448].
  • 46. Rostami Dovom M, Ramezani Tehrani F, Djalalinia S, Cheraghi L, Behboudi Gandavani S, Azizi F. Menstrual cycle irregularity and metabolic disorders: A population-based prospective study. PLoS One. 2016;11(12). e0168402. doi: 10.1371/journal.pone.0168402. [PubMed: 27992506]. [PubMed Central: PMC5161370].
  • 47. Panidis D, Tziomalos K, Chatzis P, Papadakis E, Delkos D, Tsourdi EA, et al. Association between menstrual cycle irregularities and endocrine and metabolic characteristics of the polycystic ovary syndrome. Eur J Endocrinol. 2013;168(2):145-52. doi: 10.1530/EJE-12-0655. [PubMed: 23109645].
  • 48. Ramezani Tehrani F, Montazeri SA, Hosseinpanah F, Cheraghi L, Erfani H, Tohidi M, et al. Trend of cardio-metabolic risk factors in polycystic ovary syndrome: A population-based prospective cohort study. PLoS One. 2015;10(9). e0137609. doi: 10.1371/journal.pone.0137609. [PubMed: 26360602]. [PubMed Central: PMC4567354].
  • 49. Cho LW, Randeva HS, Atkin SL. Cardiometabolic aspects of polycystic ovarian syndrome. Vasc Health Risk Manag. 2007;3(1):55-63. [PubMed: 17583175]. [PubMed Central: PMC1994046].
  • 50. Moran LJ, Misso ML, Wild RA, Norman RJ. Impaired glucose tolerance, type 2 diabetes and metabolic syndrome in polycystic ovary syndrome: A systematic review and meta-analysis. Hum Reprod Update. 2010;16(4):347-63. doi: 10.1093/humupd/dmq001. [PubMed: 20159883].
Creative Commons License Except where otherwise noted, this work is licensed under Creative Commons Attribution Non Commercial 4.0 International License .

Search Relations:

Author(s):

Article(s):

Create Citiation Alert
via Google Reader

Readers' Comments